Clinical Medicine Insights: Oncology (Jan 2014)

Case Report about Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test

  • Benoît Dupont,
  • Delphine Mariotte,
  • Cristian Moldovan,
  • Jean-Michel Grellard,
  • Marie-Claude Vergnaud,
  • Dominique Laroche,
  • Radj Gervais

DOI
https://doi.org/10.4137/CMO.S13897
Journal volume & issue
Vol. 8

Abstract

Read online

Hypersensitivity reactions are a classic side effect of cetuximab. We report the cases of three patients who developed life-threatening hypersensitivity to cetuximab, which could have been predicted by assessing the concentration of serum anticetuximab immunoglobulin (Ig)E. The anti-cetuximab IgE concentration could be an interesting test to predict which patients are at risk of experiencing severe hypersensitivity reactions to cetuximab.